Medidata Solutions, Inc. (NASDAQ:MDSO) provides software solutions worldwide for pharmaceutical, biotechnology and medical device companies. Medidata’s board has approved a takeover offer which is subject to shareholder approval. While Medidata is a strong growth stock, it’s also an expensive stock that’s vulnerable to a price correction, so I would vote in favor of the takeover deal.
The Takeover Deal
The French listed Dassault Systèmes (DASTY) (DASTF) has made an offer to acquire Medidata for $92.25 per share in cash. Medidata’s board unanimously approved the deal on June 12, 2019 which is subject to